Invention Grant
US08436045B2 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
有权
使用2,5-二羟基苯衍生物治疗光化性角化病
- Patent Title: Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
- Patent Title (中): 使用2,5-二羟基苯衍生物治疗光化性角化病
-
Application No.: US12946742Application Date: 2010-11-15
-
Publication No.: US08436045B2Publication Date: 2013-05-07
- Inventor: Pedro Cuevas Sánchez
- Applicant: Pedro Cuevas Sánchez
- Applicant Address: US NJ Bridgewater
- Assignee: AmDerma Pharmaceuticals, LLC
- Current Assignee: AmDerma Pharmaceuticals, LLC
- Current Assignee Address: US NJ Bridgewater
- Agency: Servilla Whitney LLC
- Agent Kenneth M. Zeidner
- Priority: ES200400371 20040217; ES200602219 20060816; ES200701857 20070702
- Main IPC: A01N41/02
- IPC: A01N41/02 ; A01N37/10 ; A61K31/255 ; A61K31/235 ; A61K31/19
Abstract:
The present invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the therapeutic and/or prophylactic treatment of, inter alia, actinic keratosis.
Public/Granted literature
- US20110257264A1 USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING ACTINIC KERATOSIS Public/Granted day:2011-10-20
Information query
